Advertisement
Singapore markets close in 1 hour 42 minutes

  • Straits Times Index

    3,282.19
    -5.56 (-0.17%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,666.93
    +382.39 (+2.21%)
     

  • FTSE 100

    8,126.71
    +47.85 (+0.59%)
     

  • Bitcoin USD

    64,296.63
    -66.78 (-0.10%)
     

  • CMC Crypto 200

    1,388.47
    -8.06 (-0.58%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • Dow

    38,085.80
    -375.12 (-0.98%)
     

  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     

  • Gold

    2,350.60
    +8.10 (+0.35%)
     

  • Crude Oil

    84.10
    +0.53 (+0.63%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • FTSE Bursa Malaysia

    1,575.01
    +5.76 (+0.37%)
     

  • Jakarta Composite Index

    7,101.29
    -54.00 (-0.75%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Why AbCellera Biologics Stock Jumped 19.4% Last Month

Keith Noonan, The Motley Fool
·2-min read
Why AbCellera Biologics Stock Jumped 19.4% Last Month

Shares of AbCellera Biologics (NASDAQ: ABCL) gained 19.4% in September, according to data from S&P Global Market Intelligence. The stock jumped in the middle of the month after the biotech company announced that it had formed a new partnership with Moderna and continued to climb after it detailed another new partnership with Everest Medicines. AbCellera published a press release on Sept. 15 announcing it had entered into a multi-year collaboration and license agreement with Moderna identify and analyze natural immune system responses to therapeutic antibodies.

Continue reading